PLAU and familial pancreatic carcinoma: High expression of urinary hormone‐type plasminogen activating factor mRNA correlates with poor overall and disease‐free survival in pancreatic cancer patients, as Professor Winter [21] described their research confirms a positive correlation between uPA serum levels and CA19‐9, as well as the negative prognostic impact of elevated uPA concentrations in pancreatic cancer patients.